[Clinical value of the potential doubling time (Tpot) measured by flow cytometry].

Abstract:

:The potential doubling time (Tpot) is defined as the time necessary to double the number of proliferating tumor cells in the absence of spontaneous cell loss. Tpot is thought to be a better index of tumor proliferation than clinically observed tumour volume doubling time. The in vivo measurement of Tpot is a possible way to detect fast growing tumours which would be better controlled by accelerated radiotherapy. The published data demonstrate the feasibility and the safety of the technique. Large variations in Tpot values were observed in tumors with similar histology, indicating an accelerated proliferation rate in some tumors. There are technical difficulties related to intra-tumor heterogeneity, sample contamination by normal cells, and inter-laboratory variability, which question the biological interpretation of Tpot. Further studies are ongoing to establish whether the in vivo measurement of Tpot 1) provides information that is independent of the "classical" prognostic factors, and 2) allows the early recognition of the patients likely to benefit from accelerated treatment.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Dubray B,Maciorowsky Z,Cosset JM,Terry NH

subject

Has Abstract

pub_date

1995-01-01 00:00:00

pages

331-8

issue

5

eissn

0007-4551

issn

1769-6917

journal_volume

82

pub_type

杂志文章,评审
  • [Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects].

    abstract::Asbestos is known as mutagenic and carcinogenic for human and is responsible for many pulmonary diseases including asbestosis, bronchogenic carcinoma and malignant pleural mesothelioma. Occupational exposure to asbestos is involved in 70-80% of all malignant pleural mesothelioma. The later presents a growing challenge...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Mohr S,Keith G,Rihn B

    更新日期:2005-11-01 00:00:00

  • On the value of response criteria in therapeutic research.

    abstract::Primary chemotherapy is the use of anticancer drugs as the first treatment in patients with localized tumor presentations for which there is an alternative but less than satisfactory treatment. Its most important feature is the preservation of the primary tumor mass as a biologic marker of response, and in this sense ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Devita VT Jr

    更新日期:1988-01-01 00:00:00

  • [Risk of cancer in patients following chronic dialysis and kidney graft].

    abstract:BACKGROUND:A high prevalence of renal insufficiency has been observed in cancer patients as well as a high incidence of de novo cancer in dialysis or renal transplant patients. MATERIAL AND METHODS:We aimed to determine the incidence of cancer in patients under dialysis and in kidney transplant recipients through a se...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1545

    authors: Janus N,Launay-Vacher V,Ferrero JM,Thariat J

    更新日期:2012-03-01 00:00:00

  • [Radioimmunotargeting: diagnosis and therapeutic use].

    abstract::Monoclonal antibodies labeled with a radionuclide make feasible the in vivo radioimmunotargeting of tumor cells. This targeting could be performed for diagnosis, using gamma emitters, or for therapeutic purpose when antibodies are labeled with beta- and in the future alpha-emitters. Diagnosis applications (tumor detec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Vuillez JP

    更新日期:2000-11-01 00:00:00

  • [Cervical pathology: significance and therapeutic impact of margin status].

    abstract::Margin status in cervical pathology is one of most important predictive factor of recurrent disease. Even if management of surgical biopsy is standardized, quality of surgical procedure is fundamental. Frozen section can be realise in order to complete surgical procedure if margins are involved. Extemporaneous exam of...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0756

    authors: Michy T,Leveque J,Loussouarn D,Dravet F,Dejode M,Sagan C,Descamps P,Classe JM

    更新日期:2008-12-01 00:00:00

  • [PAX gene function during kidney tumorigenesis: a comparative approach].

    abstract::The rising incidence of cancers affecting the kidney emphasizes the need to identify the molecular pathways involved in the initiation and progression of kidney tumors in order to counter this phenomenon. For many years, genes belonging to the PAX family have been the focus of intensive studies in the fields of organo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Béland M,Bouchard M

    更新日期:2006-09-01 00:00:00

  • Determinants of 5-fluorouracil sensitivity in human tumors.

    abstract::It is not apparent that advanced human carcinomas of the breast or the large bowel are conprised of at least two populations: those responding to treatment with 5-fluorouracil (approximately 20 per cent) and those unresponsive to this drug. This classification cannot be made before chemotherapy on the basis of any cli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Moran RG,Heidelberger C

    更新日期:1979-01-01 00:00:00

  • [Translation and validation of Brief Edinburgh Depression Scale (BEDS) in French].

    abstract:BACKGROUND:Depression is an important symptom for many palliative care patients but is rarely identified. It's known to reduce quality of life and impact on palliation of physical symptom. These physical symptoms can be improved by an adequate treatment of depression. Many depressed cancer patients are not treated due ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1310

    authors: Rhondali W,Perceau E,Saltel P,Girard R,Filbet M

    更新日期:2011-02-01 00:00:00

  • Image guided radiotherapy for prostate cancer.

    abstract::The purpose of external beam radiotherapy is to sterilize malignant tumours and at the same time to avoid complications by radiation injury to the surrounding healthy tissues. Modern radiation techniques in recent years have allowed to safely escalate the dose by approximately 10% for the treatment of prostate cancer,...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0599

    authors: Soete G,Verellen D,Storme G

    更新日期:2008-03-01 00:00:00

  • [What's new in the treatment of cancer pain?].

    abstract::Improvements have been made recently in the treatment of cancer pain. First of all, this symptom is better recognized and evaluated in cancer patients. Then new therapeutic options have became available in France : tramadol, WHO level II analgesic, for intermediate to severe pain; gabapentine, a new anticonvulsivant d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Di Palma M,Poulain P,Pichard E

    更新日期:2004-01-01 00:00:00

  • Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.

    abstract:BACKGROUND:The standard treatment in first line of advanced or metastatic urothelial bladder cancer (MBC) is the association of Gemcitabine and Cisplatin (GC). Avelumab, an anti-PD-L1 agent, has recently demonstrated efficacy. The objective is to evaluate the combination of these 3 agents. METHODS:This phase II random...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30280-0

    authors: Gross-Goupil M,Domblides C,Lefort F,Ravaud A

    更新日期:2020-06-01 00:00:00

  • [Access to fertility preservation for adolescents and young adults aged 15 to 24 years with cancers in Auvergne, France].

    abstract:INTRODUCTION:Cancers of adolescents and young adults have particular epidemiological specificities. The improvement in their survival should be accompanied by an increased consideration of the treatments' side effects, among which the potential decrease in fertility. The objective of the study was to describe the acces...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.03.013

    authors: Grèze V,Mechdoud S,Vorilhon S,Isfan F,Rouel N,Chaput L,Brugnon F,Kanold J

    更新日期:2020-01-01 00:00:00

  • [Adjuvant treatment of colon cancer MOSAIC study's main results].

    abstract::Oxaliplatin in combination with 5-fluorouracil/leucovorin (LV5FU) improves the response rate and survival of patients with metastatic colorectal cancer. The objective of the Mosaic study was to evaluate the efficacy of this association in the adjuvant treatment of stage II and III colon cancer. This international stud...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: André T,Tournigand C,Achille E,Tubiana-Mathieu N,Lledo G,Raoul Y,Carola E,Flesch M,Muron T,Boutan-Laroze A,Guérin Meyer V,Boaziz C,Maigre M,Ganem G,Mousseau M,Mounedji-Boudiaf L,de Gramont A

    更新日期:2006-02-01 00:00:00

  • [Treatment of locally extensive soft tissue sarcomas. Value of intra-arterial chemotherapy (author's transl)].

    abstract::Between 1964 and 1978, 21 patients with locally extensive soft tissue sarcoma received intal-arterial regional chemotherapy (IAC), combined with radiotherapy. Some patients were also submitted to conservative surgery. Although there were three serious accidents, one of which was lethal, the tolerance was considered ac...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Marée D,Bui NB,Chauvergne J,Avril A,Richaud P

    更新日期:1980-01-01 00:00:00

  • [Brachytherapy for prostate cancer: old concept, new techniques].

    abstract::Whereas it has been proposed almost one century ago, brachytherapy for prostate cancer has only recently emerged, especially thanks to endorectal echography, allowing to visualize seed implantation, to the development of seeds for permanent delivery and of micro-sources for high-dose rate delivery, and also to the dev...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cosset JM,Flam T,Thiounn N,Rosenwald JC,Pontvert D,Timbert M,Solignac S,Chauveinc L

    更新日期:2006-08-01 00:00:00

  • [Gangliosides and cancer].

    abstract::Gangliosides are glycosphingolipids which contain neuraminic acid. Although they are present in the plasma membranes of all cells, gangliosides are expressed differently, both quantitatively and qualitatively, in certain types of cancer. Modifications in ganglioside composition may account for some of the abnormal int...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dumontet C,Portoukalian J

    更新日期:1991-01-01 00:00:00

  • [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].

    abstract::The antiestrogen tamoxifen (TAM) has been successfully used to treat breast cancer expressing estrogen and progesterone receptors (ER+ and PR+). However, the development of antiestrogen resistance is frequently observed in patients following long-term treatment. To better understand the mechanism of action of TAM and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachmann-Moisson N,Barberi-Heyob M,Merlin JL,Ledrich ML,Batt AM,Guillemin F

    更新日期:1996-10-01 00:00:00

  • [Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to express a chimeric antigen receptor targeting an antigen expressed on tumor cells such as CD19. CAR T-cells represent a new class of medicinal products, and belong to the broad category of Advanced Therapy Medicinal Products ...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2017.10.017

    authors: Yakoub-Agha I,Ferrand C,Chalandon Y,Ballot C,Castilla Llorente C,Deschamps M,Gauthier J,Labalette M,Larghero J,Maheux C,Moreau AS,Varlet P,Pétillon MO,Pinturaud M,Rubio MT,Chabannon C

    更新日期:2017-12-01 00:00:00

  • [Postmastectomy pain syndrome evidence based guidelines and decision trees].

    abstract::A multidisciplinary expert group had reviewed all scientific data available of post mastectomy pain syndrome. Seventy six publications were retained and thirty evidence based diagnosis, treatment and follow-up recommendations are listed. Few of theses recommendations are classed level A. Datas analysis make possible t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:

    authors: Labrèze L,Dixmérias-Iskandar F,Monnin D,Bussières E,Delahaye E,Bernard D,Lakdja F

    更新日期:2007-03-01 00:00:00

  • [Conservative management of malignant and borderline ovarian tumor].

    abstract::Conservative management of at least a part of one ovary and the uterus, in order to preserve fertility-potential, could be propose in most of patients with nonepithelial and borderline ovarian tumor. This conservative management could be performed even in patients with borderline ovarian tumor associated with noninvas...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Morice P,Camatte S,Wickart-Poque F,Rouzier R,Pautier P,Pomel C,Lhommé C,Haie-Meder C,Duvillard P,Castaigne D

    更新日期:2002-12-01 00:00:00

  • [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].

    abstract::Tamoxifen is widely used nowadays in the management of breast cancer, having established its efficacy in this indication, especially for postmenopausal patients with ER-positive breast tumours. However, tamoxifen has recently been recognized as carcinogenic for the human endometrium, probably with an effect of duratio...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,多中心研究,评审

    doi:

    authors: Sasco AJ,Ah-Song R,Gendre I,Zlatoff P,Bobin JY,Hallonet P,Leduc B

    更新日期:1997-01-01 00:00:00

  • [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].

    abstract::We evaluated the efficacy and safety of a monotherapy by piperacillin and sulbactam potentially associated to vancomycin as an empiric antimicrobial therapy in febrile neutropenic patients treated with nephrotoxic chemotherapy for solid tumors. Twenty-three patients were treated during 32 episodes with piperacillin 4 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Abs L,Kattan J,Culine S,Bekradda M,Farhat F,Droz JP

    更新日期:1994-10-01 00:00:00

  • [Primary cerebral tumors in children. II: Topography and treatment].

    abstract::In part I of this article, we reviewed the general aspects of childhood brain tumors. In part II, we present the most common neoplasms and their treatment. The quality of the surgical resection appears to be of first importance in the prognosis. Progress in radiotherapy and chemotherapy have contributed to the improve...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Carrie C,Bouffet E,Brunat-Mentigny M,Philip T,Lacroze M

    更新日期:1989-01-01 00:00:00

  • [Region-wide professional practice evaluation with regards to antiemetic prescription into chemotherapy-induced nausea and vomiting].

    abstract::The anticancer drug technical commission (COTECH) of the Auvergne OMEDIT has set up a region-wide professional practice evaluation (PPE) with regards to antiemetic prescription practices in chemotherapy-induced nausea and vomiting (CINV), in order to evaluate their compliance with OMEDIT's guidelines. Are not included...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.03.009

    authors: Tavernier J,Jouannet-Romaszko M,Bertucat H,Marchiset N,Bahadoor M,Chevrier R

    更新日期:2016-07-01 00:00:00

  • [Immune-checkpoints: the new anti-cancer immunotherapies].

    abstract::The immune system plays a dual role against cancer: it prevents tumor cell outgrowth and also sculpts the immunogenicity of the tumor cells. Cancer cells are able to escape from the immune system by inhibiting T lymphocytes activation. New immunotherapies have been developped to target these T lymphocytes activation m...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1771

    authors: Ileana E,Champiat S,Soria JC

    更新日期:2013-06-01 00:00:00

  • [Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic haematopoietic cell transplantation (allo-HCT) is a potentially curative option, in particular in the case of relapse after autologous stem cell transp...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2017.08.008

    authors: Gauthier J,Chantepie S,Bouabdallah K,Jost E,Nguyen S,Gac AC,Damaj G,Duléry R,Michallet M,Delage J,Lewalle P,Morschhauser F,Salles G,Yakoub-Agha I,Cornillon J

    更新日期:2017-12-01 00:00:00

  • [Molecular aspects of head and neck, and lung cancer oncogenesis].

    abstract::Lung and head and neck cancers result from a multistep process involving activation of oncogenes and inactivation of tumor-suppressor genes. These two processes share common features and molecular players, while their corresponding clinical entities are both triggered by the tobacco carcinogens. In many cases, the mol...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.0786

    authors: Loriot Y,Mordant P,Fouret P,Deutsch E,Soria JC

    更新日期:2009-01-01 00:00:00

  • Is the proportion of hypoxic cells in a solid tumour dependent on the host (mouse or rat)?

    abstract::Hypoxic cell fraction was measured in a human tumour xenografted on two different animal species: mouse and rat. These results suggest that, while the Na11 tumour response to radiation depends on the host (nude mouse, nude rat), the proportion of hypoxic cells tested with the growth delay assay is independent of the h...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Guichard M,Chavaudra N,Malaise EP

    更新日期:1989-01-01 00:00:00

  • [Clinical activity spectrum of irinotecan].

    abstract::Irinotecan (CPT11), a topoisomerase I inhibitor, is a new cytotoxic agent with a broad spectrum of clinical activity. Two main schedules have been studied and produce similar activity and side-effects: the "european" one--350 mg/m2 every 21 days-, and the "japanese-north american" one where CPT11 is given at a weekly ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cottu PH,Extra JM,Lerebours F,Espie M,Marty M

    更新日期:1998-12-01 00:00:00

  • [Role of the epithelial-mesenchymal transition during tumor progression].

    abstract::The epithelial-mesenchymal transition (EMT) is a morphogenetic program that converts epithelial into mesenchymal cells during the embryonic development. This mechanism is frequently reactivated during tumor progression and provides cells with motility and invasive capabilities favoring the metastatic dissemination fro...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.1025

    authors: Ansieau S,Caron de Fromentel C,Bastid J,Morel AP,Puisieux A

    更新日期:2010-01-01 00:00:00